Role of CD20+ T cells in multiple sclerosis: implications for treatment with ocrelizumab
Stefan Gingele
Thomas Skripuletz
Roland Jacobs
Machine-generated Keywords：
Publication Date：2020-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：2( 663-664 )